Eevia Health Plc makes adjustments to the Financial calendar

Eevia Health Plc ("Eevia" or "The Company") announces adjustments to the planned dates for the release of its Interim Report for Q1-2024, its statutory financial statements for 2023, and the date of its Annual General Meeting (AGM) of Shareholders.

For practical reasons and due to the timing of public holidays during the month of May, Eevia is adjusting its financial calendar, and is announcing the following:

The publication of the Interim Report for Q1-2024 will be changed from May 20 to May 22, 2024, due to public holidays in Finland and Norway.

Eevia will publish its statutory financial statements and the auditor's report on June 7, 2024.

Eevia will hold its Annual General Meeting of the Shareholders (AGM) on Friday, June 28, 2024. The notice for the AGM will be published on June 7, 2024.

For further information, please contact:

Stein Ulve, CEO, Eevia Health Plc                          

Email: [email protected]  or [email protected]                     

Telephone: +358 400 22 5967       


Eevia Health Plc, founded in March 2017, addresses significant health problems with bioactive compounds extracted from plant materials. The materials are primarily wild harvested from the pristine Finnish and Swedish forests near or above the Arctic Circle. The extracts are sold B2B as ingredients in dietary supplements and food brands globally. These global brands utilize the ingredients in their consumer product formulas.

Eevia Health is a manufacturer of 100% organically certified plant extracts. Although a significant product, Elderberry extract, is made from cultivated berries, most of Eevia's other raw materials, such as bilberry, lingonberry, chaga-mushroom, and pine bark, are wild-harvested sustainably.

Eevia Health operates a modern green-chemistry production facility in Finland. Manufacturing natural ingredients near the raw material harvest areas, Eevia offers a short value chain with an environmentally friendly carbon footprint, competitive pricing, and extreme transparency. In June 2021, Eevia listed its shares on the Spotlight Stock Market in Sweden under the short name (ticker) EEVIA.

To learn more, please visit or follow Eevia Health on LinkedIn@EeviaHealth. 

Om Eevia Health

Eevia Health targets health problems with bioactive extracts from plant material. The human body has an incredible ability to restore good health. However, sometimes the body needs active support. Our mission is to support good health and well-being with plant extracts which have scientifically documented health benefits. Eevia Health manufactures and markets organic ingredients from abundant plant material in the Arctic. Our products are targeted against low-grade inflammation, problems in eye and brain health, and metabolic effects. We collaborate with scientists in Finland and abroad to scientifically substantiate the positive effects of ingredients and also to document the safety of use.



Kurs ()
Förändring ()
Marknad Spotlight stock market Kortnamn EEVIA ISIN-kod FI4000496658


Stein Ulve IR-kontakt [email protected]